Advancing Minimally Invasive Spinal Surgery

During 25 years of active spinal surgical practice and over 6,000 surgeries, Dr. Jeffrey Kleiner became increasingly aware that instrument design and quality played a significant role in the clinical outcome of spinal surgery.  He recognized key gaps in the instrumentation available to spinal surgeons, and this led him to develop a series of innovative solutions. 

In 2013, Dr. Kleiner established Kleiner Device Labs® (KDL) to build and sell innovative spinal surgical products.  These novel and advanced products aim to deliver improvements in efficiency and safety for patients and enable surgeons to perform more effective and less complicated fusion surgery. 

KDL's first product, a bi-directional graft delivery system (KG 1), works with any flowable biologic graft material, provides a more efficient and safer delivery vehicle for bone graft extenders, facilitates grafting for all types of interbody cages and can eliminate or reduce surgeon dependency on chemical adjuvants.  

Building on the underlying philosophy behind the KG 1 device, KDL developed the KG 2 Surge Flow-Thru Interbody Implant in 2021. No other device integrates implant positioning and graft delivery like the KG 2 Surge. The system maximizes potential for a successful fusion and simplifies the surgical procedure by combining steps. Cost reduction is anticipated because of reduced operating and anesthesia time and the reduction in surgical instrument passes should decrease the chance of nerve trauma.

KDL has a broad patent portfolio and a runway of innovative minimally invasive spinal surgical products. These strategies are equally effective in open theater surgical techniques, as well.